THIRUVANANTHAPURAM: Two new centres of excellence, focusing on specific areas of advanced research and training, have come up ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback